Penserra Capital Management LLC Axsome Therapeutics, Inc. Transaction History

Penserra Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$30.7 - $43.36 $26,555 - $37,506	-865 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$19.91 - $68.26 $199 - $682	10 Added 1.17%	865 $28,000
Q2 2021 Aug 12, 2021	BUY	$50.63 - $73.5 $759 - $1,102	15 Added 1.79%	855 $57,000
Q1 2021 May 13, 2021	SELL	$55.91 - $81.44 $838 - $1,221	-15 Reduced 1.75%	840 $47,000
Q4 2020 Feb 12, 2021	BUY	$66.31 - $86.52 $35,475 - $46,288	535 Added 167.19%	855 $69,000
Q3 2020 Nov 13, 2020	BUY	$68.34 - $85.84 $21,868 - $27,468	320 New	320 $22,000

325

37.7M

912K

855K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.73B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.